Apple has prepared modified Apple Watch models that could help it to avoid an import ban caused by a patent dispute with a California tech firm.
Apple has moved to avoid a U.S. import ban impacting the Apple Watch Series 9 and Ultra 2 caused by a patent dispute with California firm Masimo.
A letter from Masimo to an appeals court judge dated January 15 said that the tech giant is able to avoid a recently instated import ban on the Apple Watch Series 9 and Ultra 2 by removing the blood oxygen app from these Apple Watches.
In the letter, Masimo says that U.S. Customs and Border Protection (CBP) decided that Apple’s redesign falls outside the scope of the International Trade Commission’s (ITC) import ban on the two devices.
It added that Apple had explained that its “redesigned Watch products definitively do not contain pulse oximetry functionality.
